BC Cancer at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
BC Cancer brings 11 presentations to ASH 2026 in New Orleans. Its program centres on lymphoma, especially diffuse large B-cell lymphoma. It includes how-I-treat teaching on large B-cell lymphoma and a national study of Richter transformation.
| Organization | ASH 2026 Attendance |
|---|---|
BC Cancer Vancouver, Canada | |
Provincial cancer care and research agency of British Columbia, part of the Provincial Health Services Authority. | Talk Fri Dec 11 3:55pm–4:50pm Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 8:00am–9:00am Talk Sun Dec 13 9:30am–11:05am New Dimensions in the Classification of Aggressive B-cell Lymphomas: What Are We Missing? Single-cell profiling, spatial gene mapping, and whole genome sequencing trace how aggressive B cell lymphomas develop from common precursor cells. Oral Sun Dec 13 9:30am–11:00am Poster Sun Dec 13 6:00pm–8:00pm Talk Mon Dec 14 10:30am–11:45am Clinical Relevance of Non-Coding Mutations Why non-coding mutations, often left by the machinery that diversifies antibodies, matter for the biology, subtypes and clinical behavior of B-cell lymphomas. Oral Mon Dec 14 10:30am–12:00pm Session Mon Dec 14 2:45pm–4:00pm Diffuse Large B-cell Lymphoma The fast-changing treatment of diffuse large B-cell lymphoma, from new first-line combinations to CAR-T cells, bispecific antibodies and other targeted drugs. Talk Mon Dec 14 2:45pm–4:00pm Frontline Therapy of Diffuse Large B-Cell Lymphoma Recent trials of new first-line combinations for diffuse large B-cell lymphoma, and how subtype, stage, risk, age and heart health guide the choice. |
Find decision makers at BC Cancer
Tell us what you sell and we’ll find the people at BC Cancer most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction